List view / Grid view
Drug Delivery Systems
Filter the results
Researchers have used nanoparticles to infuse a non-opioid drug into nerves to provide enhanced pain relief.
A study has created microscopic tori, doughnut-shaped discs, that mimic bacteria and could be used as a form of targeted drug delivery.
A new report has predicted that the global subcutaneous drug delivery devices market will grow to $17,290.47 million in 2027 from $9,243.80 million in 2018.
A study has shown that macroscopic hollow spheres can be distorted to deflate and potentially release their contents, which could be imitated by microscopic drug delivery techniques.
A new liquid formulation of hydroxycarbamide to treat sickle cell disease will “enable doctors to personalise doses in children".
Encapsulation technology, a simple and efficient technique to coat liquid medication in milliseconds, could improve drug delivery.
A new drug delivery technology has been developed using nanotubes which can efficiently and precisely target lung cancer cells.
The fight against antibiotic resistance could be improved with the discovery of a concept for fabricating nanomeshes as a drug delivery system.
Marketing authorisation in the EU for Baqsimi, the first non-injectable treatment for very low levels of blood sugar, has been recommended by an EMA committee.
A Phase II trial for an inhaled cystic fibrosis drug, intended for adults and adolescents, has enrolled its first patient.
Scientists have found a way to effectively transport medication into the brain which could lead to improved treatments for neurological and neurodegenerative diseases.
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generics industries. Nemera always puts patients first, providing high-quality solutions that have a demonstrable impact on patients’ health, including off-the-shelf innovative systems, customized design development and GMP contract manufacturing.